Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EIT to Evaluate Ropivacaine Concentrations During Intercostal Nerve Blockade
NCT07079436Completed
- Sponsor
- Fudan University
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in breast neoplasms (3 arms), sponsored by Fudan University. Primary endpoint: Percentage decrease of the surgical side lung ventilation to total lung ventilation after blockade. Started Jul 2025; status: completed.
02
Drugs
ropivacaine
03
Conditions
breast neoplasms
Beyond the preview
Go deeper on NCT07079436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07079436.